Pulmatrix to merge with Eos SENOLYTIX; Eos stockholders to own ~94% of combined company

Pulmatrix, Inc.

Pre-Merger Eos stockholders to own ~94% of combined company; Pulmatrix stockholders ~6% on fully-diluted basis.
Combined company to be renamed 'Eos SENOLYTIX, Inc.'; board of 6 members, 5 designated by Eos.
Pulmatrix raises $1M via Series B Convertible Preferred (8% dividend, conversion at $2.20) from Eos affiliate.
Eos to raise up to $18M via convertible notes (8% interest) and Series A Preferred financing.
Closing conditions include stockholder approvals, Nasdaq listing, and SEC registration statement effectiveness.

item 1.01 item 3.02 item 3.03 item 5.01 item 5.03 item 7.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.